Carbamazepine
(CBZ) is used in the treatment of multiple neurological
conditions. Although efficacious, its potential has been limited by
its poor solubility, which means that patients are required to take
very large doses to gain the desired effect. Co-crystals have been
proposed as a means of improving the physicochemical properties of
pharmaceutical compounds while maintaining their efficacy. CBZ cocrystallized
with saccharin (SAC) and nicotinamide (NIC) have previously been studied,
with the CBZ-SAC crystal being more soluble than the commercially
available product Tegretol, which only contains CBZ, while the nicotinamide
cocrystal was found to be less soluble. High-resolution X-ray crystallography
has been carried out on the CBZ-SAC cocrystal and its individual constituents
to determine which features of the electron density distribution contribute
to the differing physical properties. The number of hydrogen bonds
found for the CBZ, SAC, and CBZ-SAC systems were 8, 5, and 10, respectively.
Homosynthons (interactions between a pair of identical functional
groups) are the primary bonding motif in CBZ and SAC, while a heterosynthon
is also present in the cocrystal. Molecular electrostatic potential
(MEP) maps show that cocrystallization results in changes in distribution
around the carboxamide group, thus accommodating heterosynthon formation
and leading to subsequent charge redistribution across the CBZ molecule.
Additional lattice energy calculations were not able to provide a
definitive answer as to which system was most stable. Solid state
entropy calculations revealed that the CBZ-SAC cocrystal had a higher
entropy, providing explanations for the lower melting point and improved
dissolution profile previously described. These investigations at
an electronic level help to explain the greater solubility of the
CBZ-SAC cocrystal compared to CBZ alone.